Unnati Pharmax continues to serve patients across the Philippines, South Africa, Australia, and Singapore with the complete antiviral range — HIV treatment and PrEP, Hepatitis B and C cure, and COVID-19 antivirals — all at WHO-GMP certified quality and dramatically more affordable pricing than branded alternatives.
Whether you are in Manila seeking Tafero EM for HIV PrEP, in Johannesburg needing Spegra for HIV treatment, in Sydney requiring Resof L for Hepatitis C cure, or in Singapore accessing Molnulee for COVID-19 — Unnati Pharmax delivers reliably via DHL and FedEx with full documentation. Visit unnatipharmax.com or WhatsApp +91 82650 41513 or email Unnatipharmax@gmail.com.
❓ FAQ 1: Why is HIV still rising in the Philippines despite global treatment advances?
The Philippines has experienced one of Southeast Asia's fastest-growing HIV epidemics, with new infections rising sharply over the past decade — primarily among MSM and young people aged 15-24. Key factors driving this include: limited sex education due to conservative cultural and religious influences, significant stigma preventing testing and treatment access, low PrEP awareness and uptake, a predominantly young epidemic where new infections are occurring in demographics with limited healthcare engagement, and gaps in the government HIV programme's reach outside major urban centres. Global treatment advances have not translated to Philippines outcomes because access, stigma, and awareness barriers prevent them from reaching the populations most at risk — which is precisely why affordable private access options like Tafero EM from Unnati Pharmax play a meaningful complementary role.
❓ FAQ 2: How does South Africa's public HIV programme compare to private access options?
South Africa's public ART programme — managed through the Department of Health — is one of the world's largest, providing free antiretrovirals to over 5 million people through public clinics and hospitals. The programme primarily uses Dolutegravir-based regimens and has dramatically reduced HIV mortality. However, significant gaps remain: administrative barriers for non-South African nationals and asylum seekers, stock-out events affecting continuity, long distances to public clinics in some areas, and stigma in community settings deterring some patients from public services. Private access through Unnati Pharmax serves those who fall outside the public programme, can afford modest private medication costs for greater privacy, or need supply continuity during disruptions to public programme access.
❓ FAQ 3: Is WHO-GMP certification sufficient assurance of medicine quality for patients in Australia and Singapore?
WHO-GMP (Good Manufacturing Practice) certification represents the internationally recognised gold standard for pharmaceutical manufacturing quality — it ensures that medicines are consistently produced to quality standards appropriate for their intended use and comply with standards required by their marketing authorisation. For Australian and Singaporean patients concerned about quality, WHO-GMP certification provides meaningful assurance: it covers facility standards, raw material testing, in-process controls, finished product testing, stability studies, and documentation systems. All Unnati Pharmax products come with full WHO-GMP certificates, certificates of analysis from accredited laboratories, and batch documentation. Australia's TGA and Singapore's HSA recognise WHO-GMP certification from approved inspection bodies, supporting the quality standing of products carrying this certification.
❓ FAQ 4: What documentation is typically included with Unnati Pharmax international shipments?
Every international shipment from Unnati Pharmax includes: the WHO-GMP certificate for the manufacturing facility, certificate of analysis (COA) confirming the specific batch's active ingredient content, purity, and compliance with pharmacopoeial specifications, manufacturer's product literature and prescribing information, customs declaration documents with correct HS codes for pharmaceutical products, and a covering letter confirming the shipment is for personal medical use (for individual patient orders). For institutional and B2B orders, additional documentation including drug master file references, regulatory compliance letters, and FSSAI compliance certificates are available on request. All documentation is in English and can be provided in PDF for regulatory submission purposes.
❓ FAQ 5: What is the typical delivery time from Nagpur to Philippines, South Africa, Australia and Singapore?
Shipping times via DHL Express International from Nagpur typically are: Australia (Sydney, Melbourne, Brisbane, Perth) — 4-7 business days; Singapore — 3-5 business days; South Africa (Johannesburg, Cape Town, Durban) — 7-10 business days; Philippines (Manila, Cebu, Davao) — 5-8 business days. These timelines include customs clearance, which is generally efficient for properly documented pharmaceutical shipments accompanied by complete paperwork. Occasionally, local customs may request additional documentation for pharmaceutical imports — our team supports customers through any such process. FedEx International Priority is also available for all markets and may offer slightly faster delivery. We recommend placing orders with adequate lead time before medication runs out to avoid treatment gaps.